L
Liliana Goumnerova
Researcher at Boston Children's Hospital
Publications - 146
Citations - 10939
Liliana Goumnerova is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medulloblastoma & Hydrocephalus. The author has an hindex of 47, co-authored 143 publications receiving 9590 citations. Previous affiliations of Liliana Goumnerova include Harvard University & University of Chicago.
Papers
More filters
Journal ArticleDOI
Prediction of central nervous system embryonal tumour outcome based on gene expression
Scott L. Pomeroy,Pablo Tamayo,Michelle Gaasenbeek,Lisa Marie Sturla,Michael Angelo,Margaret McLaughlin,John Y.H. Kim,Liliana Goumnerova,Peter McL. Black,Ching C. Lau,Jeffrey C. Allen,David Zagzag,James M. Olson,Tom Curran,Cynthia Wetmore,Jaclyn A. Biegel,Tomaso Poggio,Shayan Mukherjee,Ryan Rifkin,Andrea Califano,Gustavo Stolovitzky,David N. Louis,Jill P. Mesirov,Eric S. Lander,Todd R. Golub,Todd R. Golub +25 more
TL;DR: It is demonstrated that medulloblastomas are molecularly distinct from other brain tumours including primitive neuroectodermal tumours, atypical teratoid/rhabdoid tumours (AT/RTs) and malignant gliomas, and it is shown that the clinical outcome of children with medullOBlastomas is highly predictable on the basis of the gene expression profiles of their tumours at diagnosis.
Journal ArticleDOI
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Yoon Jae Cho,Aviad Tsherniak,Pablo Tamayo,Sandro Santagata,Azra H. Ligon,Heidi Greulich,Rameen Berhoukim,Vladimir Amani,Liliana Goumnerova,Charles G. Eberhart,Ching C. Lau,James M. Olson,Richard J. Gilbertson,Amar Gajjar,Olivier Delattre,Marcel Kool,Keith L. Ligon,Matthew Meyerson,Jill P. Mesirov,Scott L. Pomeroy +19 more
TL;DR: It is shown that a previously unidentified molecular subgroup, characterized genetically by c-MYC copy number gains and transcriptionally by enrichment of photoreceptor pathways and increased miR-183∼96∼182 expression, is associated with significantly lower rates of event-free and overall survivals.
Journal ArticleDOI
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
Mariella G. Filbin,Itay Tirosh,Itay Tirosh,Volker Hovestadt,Volker Hovestadt,McKenzie Shaw,McKenzie Shaw,Leah E. Escalante,Leah E. Escalante,Nathan Mathewson,Cyril Neftel,Nelli Frank,Kristine Pelton,Christine M. Hebert,Christine M. Hebert,Christine Haberler,Keren Yizhak,Johannes Gojo,Kristof Egervari,Christopher Mount,Peter van Galen,Peter van Galen,Dennis M. Bonal,Quang-Dé Nguyen,Alexander M. Beck,Claire Sinai,Claire Sinai,Thomas Czech,Christian Dorfer,Liliana Goumnerova,Cinzia Lavarino,Angel M. Carcaboso,Jaume Mora,Ravindra Mylvaganam,Christina C. Luo,Andreas Peyrl,Mara Popović,Amedeo A. Azizi,Tracy T. Batchelor,Matthew P. Frosch,Maria Martinez-Lage,Mark W. Kieran,Pratiti Bandopadhayay,Pratiti Bandopadhayay,Rameen Beroukhim,Rameen Beroukhim,Gerhard Fritsch,Gad Getz,Gad Getz,Orit Rozenblatt-Rosen,Kai W. Wucherpfennig,David N. Louis,Michelle Monje,Irene Slavc,Keith L. Ligon,Keith L. Ligon,Keith L. Ligon,Todd R. Golub,Todd R. Golub,Aviv Regev,Aviv Regev,Bradley E. Bernstein,Bradley E. Bernstein,Mario L. Suvà,Mario L. Suvà +64 more
TL;DR: This study characterizes oncogenic and developmental programs in H3K27M-glioma at single-cell resolution and across genetic subclones, suggesting potential therapeutic targets in this disease.
Journal ArticleDOI
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Adam M. Fontebasso,Simon Papillon-Cavanagh,Jeremy Schwartzentruber,Hamid Nikbakht,Noha Gerges,Pierre Fiset,Denise Bechet,Damien Faury,Nicolas De Jay,Lori A. Ramkissoon,Aoife Corcoran,David T.W. Jones,Dominik Sturm,Pascal Johann,Tadanori Tomita,Stewart Goldman,Mahmoud Nagib,Anne Bendel,Liliana Goumnerova,Daniel C. Bowers,Jeffrey R. Leonard,Joshua B. Rubin,Tord D. Alden,Samuel R. Browd,J. Russell Geyer,Sarah Leary,George I. Jallo,Kenneth J. Cohen,Nalin Gupta,Michael D. Prados,Anne Sophie Carret,Benjamin Ellezam,Louis Crevier,Almos Klekner,László Bognár,Peter Hauser,Miklós Garami,John S. Myseros,Zhifeng Dong,Peter M. Siegel,Hayley Malkin,Azra H. Ligon,Steffen Albrecht,Stefan M. Pfister,Keith L. Ligon,Jacek Majewski,Nada Jabado,Mark W. Kieran +47 more
TL;DR: Global DNA methylation profiles were significantly associated with the p.Lys27Met alteration, regardless of the mutant histone H3 variant and irrespective of tumor location, supporting the role of this substitution in driving the epigenetic phenotype.
Journal ArticleDOI
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor
Susan N. Chi,Mary Ann Zimmerman,Xiaopan Yao,Kenneth J. Cohen,Peter C. Burger,Jaclyn A. Biegel,Lucy B. Rorke-Adams,Michael J. Fisher,Anna J. Janss,Claire Mazewski,Stewart Goldman,Peter E. Manley,Daniel C. Bowers,Anne Bendel,Joshua B. Rubin,Christopher D. Turner,Karen J. Marcus,Liliana Goumnerova,Nicole J. Ullrich,Mark W. Kieran +19 more
TL;DR: This intensive multimodality regimen has resulted in a significant improvement in time to progression and overall survival for patients with this previously poor-prognosis CNS ATRT.